About iNDX.Ai
Problems We Are Solving
The genomics revolution has created a data tsunami. We have developed a novel & proprietary work flow for managing Precision medicine clinical trials and Translational research. Our software platform is solving the following problems.
-
Difficulties in correlating clinical data and exploratory data
-
Problems related to understanding the MOA for new clinical trial candidates
-
Issues related to proper monitoring of the subject’s health during a clinical trial
-
Roadblocks in the analysis of diverse multi-omics and clinical datasets that prevent investigators from gathering predictive insights


Our Vision
“Our vision is to provide an innovative platform to help you find the right medicine for the right patients at the right time, regionally and globally. We are looking for a few good men and women across different disciplines who have passion for this mission and take great pride in building game-changing products and solutions for cancer patients around the world and who believe in our principles”
Our Mission
“Our mission is to be the technology catalyst to enable our collaborators/customers to find a cure for cancer, COVID-19, and rare orphan diseases. It is our firm belief that the intersection of innovations in technology, science, and business is the only way to fight the deadly disease.”

Board of Directors and Advisors

John Dean
Managing Partner, Startup Capital VC

Mohan Uttarwar
Chief Executive Officer, iNDX.Ai

Dr. Arun Jamkar
Chief Medical Officer

Dr. Gowhar Shafi
VP, Computational Biology & Translational Research

Deelip Mhaske
Business Advisor

Dr. Richard Friedberg MD, PhD
President- College of American Pathologists (CAP)

Carol Berry MBA
Senior Vice-President and Chief Business Officer, Caption

Prasun Mishra
Chief Executive Officer, Agility Pharmaceuticals

Dr. Stefan Scherer
Global Head Experimental Medicine at GSK

Dr. Rob Monroe MD PhD
Chief Medical Officer at Bio-Techne & Advanced Cell Diagnostics, Pathologist

Dr. Darshan Gandhi MD
Oncology Physician, Texas Oncology-Methodist Charlton Cancer Center
CM.png)
Kelly Gordon, Ph.D., MB(ASCP)CM
Entrepreneur, Owner at Boudicca Dx., LLC

Dr. Rupesh Chaturvedi
Biomedical researcher/ Innovator

Piyush Gupta
Advisor at Arka Venture Labs

Denis Coleman, PhD
Strategic Advisor, Startup Capital Venture

Hans-Burghardt Ziermann
Managing Partner at Mobil Consult GmbH
Quick Facts

Expertise
Highly skilled employees in multidisciplinary teams

Global
Offices in USA and India, Partnered with Avantor in Europe

Security
Global Standards in Data Protection
.png)
Tracking Automation
Biospecimen workflow for efficient trial operations

Actionable biological insights
Overcome insights missed by traditional bioinformatics tools.

Technology
Leveraging AI, ML, and NLP
